HYPERTHYROIDISM AND ATRIAL FIBRILLATION

QR Code

HYPERTHYROIDISM AND ATRIAL FIBRILLATION

Review on a problem of the development of atrial fibrillation in patients with thyrotoxicosis is presented. Thyrotoxicosis is one of the most frequent endocrine diseases, conceding only to a diabetes mellitus. The most frequent reasons of hyperthyroidism are Graves’ disease and functional thyroid au...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. M. Marusenko, E. G. Petrova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2017-07-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	thyrotoxicosis atrial fibrillation thyrotoxic cardiomyopathy left ventricular hypertrophy
Online Access:	https://www.rpcardio.online/jour/article/view/1492
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Complicated course of diffuse toxic goiter in a puberty patient (clinical observation)
by: V. G. Chobitko, et al.
Published: (2021-06-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

ВОЗРАСТНЫЕ ОСОБЕННОСТИ ДИФФУЗНОГО ТОКСИЧЕСКОГО ЗОБА. СЛУЧАЙ ИЗ ПРАКТИКИ
by: Л. М. Фархутдинова, et al.
Published: (2015-06-01)

Thyrotoxic periodic paralysis. A case report
by: G. R. Ramazanov, et al.
Published: (2022-11-01)

ATRIAL FIBRILLATION AND FLUTTER IN HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2015-05-01)

Atrial Fibrillation and Heart Failure as the Onset of AL-Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-11-01)

DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
by: An. A. Aleksandrov, et al.
Published: (2015-09-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021-05-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
by: O. V. Gaisenok
Published: (2016-01-01)

ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: O. N. Miller, et al.
Published: (2011-08-01)

Novel diagnostic criteria for atrial cardiomyopathy in patients with type 2 diabetes and atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2021-04-01)

In search of heart barometer—advantage of left atrial dimension over electrocardiographic indices of left ventricular hypertrophy in arterial hypertension
by: Bogusława Nowak, et al.
Published: (2023-07-01)

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
by: I. V. Zhirov, et al.
Published: (2021-02-01)

Additional diagnostic criteria for atrial cardiomyopathy in patients with lone atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2021-02-01)

Left atrial strain as a predictor of atrial fibrillation in patients with asymptomatic severe aortic stenosis and preserved left ventricular systolic function
by: A. L. Chilingaryan, et al.
Published: (2022-08-01)

Predictors of thrombosis of left atrium and its appendage before catheter ablation or cardioversion in patients with non-valvular atrial fibrillation or atrial flutter
by: I. A. Zaigraev, et al.
Published: (2023-01-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

Retrospective analysis of cardiovascular involvement in patients with systemic amyloidosis
by: E. V. Reznik, et al.
Published: (2021-02-01)

Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice
by: Gerhild Euler, et al.
Published: (2025-07-01)

ENDOVASCULAR METHODS FOR CLOSURE OF THE LEFT ATRIAL APPENDAGE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION FOR STROKE PREVENTION
by: R. V. Guchaev, et al.
Published: (2018-05-01)

Patterns of structural and functional remodeling of the left ventricle in patients with various forms of atrial fibrillation
by: A. I. Kochetkov, et al.
Published: (2024-04-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
by: E. V. Kokhan, et al.
Published: (2021-07-01)

Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients
by: Akihiro Sunaga, et al.
Published: (2025-08-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
by: D. A. Kuzhel, et al.
Published: (2016-01-01)

ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS
by: R. Bhattarai, et al.
Published: (2015-09-01)

Left heart remodeling as a risk factor for atrial fibrillation in patients after surgery of acquired heart defects
by: I. I. Averina, et al.
Published: (2023-08-01)

Associations of the left atrial epicardial fat thickness with the thrombosis prevalence and left atrial appendage flow velocity in patients with persistent non-valvular atrial fibrillation
by: E. S. Mazur, et al.
Published: (2024-05-01)

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)

Prognostic role of atrial fibrillation in patients with non-compaction cardiomyopathy
by: S. M. Komissarova, et al.
Published: (2023-09-01)

Left Atrial Remodeling Identification and Catheter Ablation Outcomes With 18F‐Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation
by: Tristan Raoult, et al.
Published: (2025-07-01)

СТРУКТУРНО-ФУНКЦИОНАЛЬНЫЕ ИЗМЕНЕНИЯ МИОКАРДА ПРИ ОЖИРЕНИИ, ИХ ДИНАМИКА НА ФОНЕ СНИЖЕНИЯ МАССЫ ТЕЛА (литературный обзор)
by: А. В. Постоева, et al.
Published: (2014-06-01)

ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART
by: M. D. Smirnova, et al.
Published: (2009-04-01)

Thromboembolic risk factors and predictors of left atrial appendage thrombosis in Far North patients with nonvalvular atrial fibrillation
by: N. Yu. Khorkova, et al.
Published: (2021-11-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling
by: Malene E. Lindholm, et al.
Published: (2025-07-01)

A new method of left atrial appendage occlusion for the prevention of thromboembolic complications in patients with atrial fibrillation during coronary artery bypass grafting
by: Yu. Yu. Vecherskiy, et al.
Published: (2020-09-01)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022-03-01)

Effect of catheter ablation for atrial fibrillation on left and right atrial function
by: T. V. Moskovskikh, et al.
Published: (2022-08-01)

Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure
by: E. V. Kokhan, et al.
Published: (2019-11-01)